Czechia – Immunosuppressive agents – LP s obsahem ofatumumabu 2026 - sdružený nákup

Fakultní Nemocnice Olomouc · Czech Republic government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$16.4M
Est. Value
October 27, 2026
Response Due
Active
Status

Opportunity Overview

Předmětem veřejné zakázky jsou opakující se dodávky léčivých přípravků splňujících požadavky SÚKL s obsahem účinné látky ofatumumab

This is one of 899 active Czech Republic Health Services opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyFakultní Nemocnice Olomouc
CountryCzech Republic
CategoryHealth Services
Estimated value$16.4M
PublishedSeptember 23, 2026
Procurement stageRequest for Proposal (RFP)
Response dueOctober 27, 2026
StatusOpen — accepting responses
TranslationTranslated from Czech by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedOctober 04, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Related Opportunities in Czech Republic

Czechia – Pharmaceutical products – Dynamický nákupní systém na dodávky léčivých přípravků
Czechia – Construction work – NOVOSTAVBA HLAVNÍ BUDOVY B A VNITŘNÍ DOSTAVBA NÍZKOPRAHOVÉHO URGENTNÍHO PŘÍJMU
Czechia – Construction work for buildings relating to health – Stavební úpravy budov H1 a H2
Czechia – Diagnostic agents – Diagnostika pro rutinní biochemická a imunochemická stanovení s výpůjčkou analytického systému
Czechia – Defibrillator – ICD s telemonitoringem, včasnou detekcí selhání srdce a zabezpečeným přenosem dat - REIMPLANTACE
Czechia – Medicinal products for the blood and blood-forming organs – Hemofilie A - Rekombinantní faktor VIII. 2026
Czechia – Antihaemorrhagics – LP s obsahem lidského fibrinogenu 2026
Czechia – Radiotherapy, mechanotherapy, electrotherapy and physical therapy devices – Hypertermie

See every Czech Republic Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Czech Republic Health Services intelligence report in your inbox

A personalized report on Czech Republic Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.